Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer

Journal of Thoracic Oncology

Volumn 12, Issue 2, 2017, Pages 293-301

  Speirs, Christina K ^a   DeWees, Todd A ^a   Rehman, Sana ^a   Molotievschi, Alerson ^b   Velez, Maria A ^a   Mullen, Daniel ^a   Fergus, Sandra ^a   Trovo, Marco ^c   Bradley, Jeffrey D ^a   Robinson, Cliff G ^a  

^a Washington University in St Louis School of Medicine   (United States)

^b Clinicas Oncologicas Integradas   (Brazil)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Cardiac toxicity; NSCLC; Radiation dosimetry; Radiation therapy; Survival outcomes

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; PACLITAXEL;

ADULT; AGED; ARTICLE; BRACHIAL PLEXUS NEUROPATHY; CARDIOTOXICITY; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOSIMETRY; ESOPHAGITIS; FEMALE; FOLLOW UP; HEART VOLUME; HUMAN; LUNG STRUCTURE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MYELITIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PNEUMONIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME; CANCER STAGING; CLINICAL TRIAL; HEART; INTENSITY MODULATED RADIATION THERAPY; LUNG TUMOR; MIDDLE AGED; MORTALITY; ORGANS AT RISK; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; RADIATION RESPONSE; RADIOMETRY; RADIOTHERAPY DOSAGE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGANS AT RISK; PROGNOSIS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 85015278896     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2016.09.134     Document Type: Article

References (23)

1. 1 Dillman, R.O., Herndon, J., Seagren, S.L., Eaton, W.L., Green, M.R., Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88 (1996), 1210–1215.
2. 2 Sause, W.T., Byhardt, R.W., Curran, W.J. Jr., et al. Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 215:suppl (2000), 1363–1372.
3. 3 Kong, F.M., Ten Haken, R.K., Schipper, M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005), 324–333.
4. 4 Aupérin, A., Le Péchoux, C., Rolland, E., et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 28 (2010), 2181–2190.
5. 5 Bradley, J.D., Paulus, R., Komaki, R., et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 16 (2015), 187–199.
6. 6 Harris, P.A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., Conde, J.G., Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42 (2009), 377–381.
7. 7 Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
8. 8 Wheatley, M.D., Gore, E.M., Bar Ad, V., Robinson, C.G., Bradley, J.D., Defining a novel cardiac contouring atlas for NSCLC using cadaveric anatomy. Int J Radiat Oncol Biol Phys, 90, 2014, S658.
9. 9 Contal, C., O'Quigley, J., An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 30 (1999), 253–270.
10. 10 Darby, S.C., Ewertz, M., McGale, P., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368 (2013), 987–998.
11. 11 Darby, S.C., Ewertz, M., Hall, P., Ischemic heart disease after breast cancer radiotherapy. N Engl J Med, 368, 2013, 2527.
12. 12 Dautzenberg, B., Arriagada, R., Chammard, A.B., et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer 86 (1999), 265–273.
13. 13 Liao, Z., Tucker, S.L., Gomez, D., et al. Heart and lung radiation and overall survival in non-small cell lung cancer patients after chemoradiation therapy. Int J Radiat Oncol, 84, 2012, S578.
14. 14 Yabroff, K.R., Lamont, E.B., Mariotto, A., et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 100 (2008), 630–641.
15. 15 Cipriano, L.E., Romanus, D., Earle, C.C., et al. Lung cancer treatment costs, including patient responsibility, by stage of disease and treatment modality, 1992–2003. Value Health 14 (2011), 41–52.
16. 16 Grotenhuis, H.B., Zhou, C., Tomlinson, G., et al. Cardiothoracic ratio on chest radiograph in pediatric heart disease: how does it correlate with heart volumes at magnetic resonance imaging?. Pediatr Radiol 45 (2015), 1616–1623.
17. 17 Chun, S.G., Hu, C., Choy, H., et al. Comparison of 3-D conformal and intensity modulated radiation therapy outcomes for locally advanced non-small cell lung cancer in NRG oncology/RTOG 0617. Int J Radiat Oncol Biol Phys 93 (2015), S1–S2.
18. 18 Chun, SG, et al. Outcomes of intensity modulated and 3D-conformal radiotherapy for stage III non-small cell lung cancer in NRG Oncology/RTOG 0617. http://library.iaslc.org/virtual-library-search?product_id=1&author=&category=&date=&session_type=&session=&presentation=&keyword=0617. Accessed April 16, 2016.
19. 19 Sejpal, S., Komaki, R., Tsao, A., et al. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer 117 (2011), 3004–3013.
20. 20 Chang, J.Y., Zhang, X., Wang, X., et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65 (2006), 1087–1096.
21. 21 Bradley, J.D., Hope, A., El Naga, I., et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 69 (2007), 985–992.
22. 22 Rehman, S., Speirs, C.K., Molotievschi, A., et al. Evaluating a nomogram for the development of radiation pneumonitis in locally advanced non-small cell lung cancer treated with 3D and intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 90 (2014), S161–S162.
23. 23 Huang, E.X., Hope, A.J., Lindsay, P.E., et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol Stockh Swed 50 (2011), 51–60.